跳至主要内容
临床试验/NCT05968443
NCT05968443已完成不适用

Observational, Retrospective Clinical Study in Patients Undergoing Ophthalmic Surgery Using Dafilon® Suture Material (Dafilon® USP (United States Pharmacopeia) Sizes From 8/0 to 11/0)

Aesculap AG1 个研究点 分布在 1 个国家目标入组 200 人开始时间: 2019年1月8日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
Aesculap AG
入组人数
200
试验地点
1
主要终点
Number of Suture material complications

研究概览

简要总结

This is an observational, retrospective postmarket clinical follow-up study and includes all patients who underwent any ophthalmic surgery using Dafilon® suture in the selected centres between 2018 and 2020, therefore no sample size can be given but the planned sample size shall be at least 200 eyes (around 100 patients depending on the number of operated eyes per patient) to conduct meaningful subgroup analysis.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

性别
All
接受健康志愿者

入选标准

  • Patient operated between 2018 - 2020 undergoing any ophthalmic surgery using Dafilon® suture material (Dafilon® USP (United States Pharmacopeia) sizes from 8/0 to 11/0) at the participating hospital

排除标准

  • No exclusion criteria have been set

结局指标

主要结局

Number of Suture material complications

时间窗: up to the retrospective examination (2 to 4 years postoperatively)

Suture material complications needing suture removal or reinterventions (Re-suturing due to wound dehiscence)

次要结局

  • Number of Intra-operative complications(intraoperatively)
  • Incidence of recurrence(up to the retrospective examination (2 to 4 years postoperatively))
  • Number of Post-operative complications(up to the retrospective examination (2 to 4 years postoperatively))

研究者

发起方
Aesculap AG
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验